624
·
11-03
Nvidia's Game-Changing Bet: All-In on US Manufacturing – Revolutionizing AI and Boosting the Economy! 🚀🇺🇸
$NVIDIA(NVDA)$ Jensen Huang, the visionary CEO of Nvidia, just dropped a bombshell announcement that's set to reshape the tech landscape. Nvidia is going "all in" on shifting manufacturing back to the United States, and Huang couldn't be more pumped: "It's great for our business, it's great for America. Everybody wins." This move comes hot on the heels of Nvidia's skyrocketing success in AI, with their cutting-edge Blackwell AI chips already ramping up production in Arizona. Imagine factories buzzing with innovation, creating jobs and securing the supply chain right here at home! 💥🔧 But why now? With global tensions and supply chain hiccups, bringing production stateside means faster innovation, reduced risks, and a massive boost to American compe
TOPMortimer Arthur: $300 coming soon... don't sell cheap...
3.21K
·
11-03
FactSet: 10 out of 11 sectors are reporting Y/Y revenue growth and 8 out of 11 sectors are reporting earnings growth for Q3. Revenue does not always translate into profits. Watch out for sectors like comms. Services, energy and consumer Staples. $IREN Ltd(IREN)$
TOPI hear this will be over 1k per share in a year or two. The birdie who told me sold all of his btc and nvidia to buy IREN. I just follow the money and the money is and will continue to pour into IREN.
1.18K
·
11-03
Should We Vote Yes To Elon Musk's USD 1 Trillion Paycheck?
🌟🌟🌟The vote on Elon Musk's USD 1 Trillion pay package is more than a compensation package. It is a referendum on Tesla's soul. On November 6, shareholders must decide : reward the architect of Tesla's $Tesla Motors(TSLA)$ or rein in the power of a man who shaped Tesla. The Case for Yes: Vision, Velocity and Value : Tesla Chair Robyn Denholm has made it clear : without Elon Musk, Tesla risks losing its edge. She is not just defending a paycheck. She is defending a legacy. Elon Musk's leadership has driven Tesla's dominance in EVs, AI and Robotics. His fingerprints are on every breakthrough : Full Self Driving, Optimism, Gigafactories and the AI Chip roadmap. The package would grant Elon Musk 423 m
TOPIt wasn't that easy to pass, Elon Musk threatened to resign on X and finally passed it unanimously
2.67K
·
11-02
My October Review & The Power of Belief In Alphabet & Nvidia
🌟🌟🌟October closed with fireworks and I am still feeling the heat. All 3 US Indexes surged and reached record highs. November continues. I call it NovemBoom when earnings explode and portfolios flow. Loud, proud and unapologetically bullish. 2 Star Performers in my portfolio for October Alphabet $Alphabet(GOOGL)$
TOPMy bet will be on another up-and-coming AI stock, which will benefit from the wave and often goes unnoticed, surprising everyone unexpectedly. Have a lovely weekend ☺️
152
·
11-03
Bitcoin: $110K Rejection Shifts Focus to $105K Support Zone
BTC/USD $107,459 (−2.78%): $110K ceiling holds as risk appetite fades; neutral zone slips toward $105K pivotMarket Recap (as of Nov 2, 2025): Bitcoin (BTC/USD) slid −2.78% to $107,459, retreating from the intraday high of $110,730 after failing to reclaim its short-term EMA zone. The day’s range $107,303–$110,730 underscores narrowing volatility, but sellers remain active near the $110K–$111K band. Yahoo Finance shows a parallel quote at $108,158 (−1.65%), with overall market cap around $2.15T and 24h volume near $43B. The correction aligns with macro caution as traders digest slower ETF inflows and a firmer dollar index.Technical Indicators Analysis: Momentum turned soft: MACD(12,26,9) lines (−1,201 vs −1,125) remain in bearish alignment, histogram flatlining around zero — signaling mome
353
·
11-03
QCOM: Post-Earnings Rally Eyes $185—Will Momentum Hold?
$Qualcomm(QCOM)$ $180.90 (+2.05%): Post-earnings relief rally holds; bulls eye $185 continuation zoneMarket Recap (as of Oct 31, 2025): Qualcomm advanced +2.05% to $180.90, extending its two-day rebound as investors reacted positively to management’s AI-chip commentary and improved handset demand outlook. Intraday range $176.83–$182.15 with volume 9.45M vs 8.89M avg, showing strong follow-through after the prior session’s 10% earnings surge. The stock is now roughly 12% off its YTD high ($205.95) but remains above all key short-term averages.Technical Indicators Analysis: Momentum remains favorable. MACD(12,26,9) at 2.78 vs 1.38 confirms a recent bullish crossover, while RSI(14) 62.4 shows moderate overbought conditions yet still room for upside.
689
·
11-03
SMCI: Rebound Holds Above $51
$SUPER MICRO COMPUTER INC(SMCI)$ $51.96 (+3.16%): AI hardware rebound steadies near $52; momentum neutralizing into earningsMarket Recap (as of Oct 31, 2025): Super Micro Computer Inc. (SMCI) closed +3.16% higher at $51.96, recovering modestly from early-week softness. Intraday range $50.80–$52.99 on volume ~19.8M (vs 30.6M avg) signals cautious accumulation ahead of next week’s earnings (Nov 4). Broader AI-server sentiment improved, tracking $NVIDIA(NVDA)$ ’s and $Advanced Micro Devices(AMD)$ ’s late-session bounce. The stock remains roughly 13% below October’s swing high near $59, stabilizing above its short-term moving averages.Technical Indicators Analysis: Mo
1.21K
·
11-03
🎁Weekly Higher EPS Estimates: PLTR, AMD, AZN, APP, MCD & More
😀Hi Tigers,We invite you to take a closer look at the possible winners by EPS in the Q3 earnings season.In this post, we have highlighted the top 20 stocks by market capitalization with an estimated higher EPS ahead of their earnings in the period from November 3 to November 7.Read more>> 🎁Capturing Top 10 Ex_dividend: BX, ETN, OKE, NVEC, PNW...1. Why EPS Matters?Earnings per share(EPS), refers to the income per share brought to investors/shareholders in the open market.EPS is calculated as a company's profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company's profitability.Investors like companies with high profitability, and the
TOPHere’s a summary of the estimated earnings per share (EPS) for several prominent companies reporting earnings from November 3 to November 7, 2025. The focus is on the estimates compared to previous periods, including critical financial metrics, analyst sentiment, and recent stock performance. 1. Palantir Technologies Inc. (PLTR) Next Earnings Date: November 3, 2025. 2025 FY EPS Estimate: $0.64 (compared to $0.40 in 2024 FY). Analyst Recommendations: 2 recommend, 4 buy, 17 hold, 2 underperform, 1 sell. Recent Stock Price: $200.47 (Resistance: $201.31, Support: $179.31). Quarterly Fluctuation: Increased by 30.26%. Options Insights: Heavy selling observed in calls with a significant volume of calls and puts indicating mixed sentiment. 2. Advanced Micro Devices (AMD) Next Earnings Date: November 4, 2025. 2025 FY EPS Estimate: $3.91 (up from $3.60 in FY 2024). Analyst Recommendations: 14 recommend, 27 buy, 13 hold, 1 sell. Recent Stock Price: $256.12 (Resistance: $258.75, Support: $234.75). Quarterly Fluctuation: Increased by 10.88%. Options Insights: High volume of calls traded, indicating bullish outlook; contrasting with some put orders suggesting hedging. 3. AstraZeneca PLC (AZN) Next Earnings Date: November 6, 2025. 2025 FY EPS Estimate: $4.58 (up from $4.20 in FY 2024). Analyst Recommendations: 4 recommend, 8 buy, 1 hold. Recent Stock Price: $82.40 (Resistance: $84.56, Support: $73.76). Quarterly Fluctuation: Increased by 5.55%. Options Insights: Notable selling in short-term call options, possibly anticipating a mixed or lower performance. 4. AppLovin Corporation (APP) Next Earnings Date: November 5, 2025. 2025 FY EPS Estimate: $8.99 (significant increase from $6.75 in FY 2024). Analyst Recommendations: 8 recommend, 15 buy, 4 hold, 1 underperform. Recent Stock Price: $637.33 (Resistance: $643.02, Support: $637.02). Quarterly Fluctuation: Dramatically increased by 91.34%. Options Insights: High activity in both call and put options indicates uncertainty and mixed sentiment among investors. 5. McDonald's (MCD) Next Earnings Date: November 5, 2025. 2025 FY EPS Estimate: $12.27 (compared to $11.50 in FY 2024). Analyst Recommendations: 5 recommend, 15 buy, 18 hold, 2 underperform. Recent Stock Price: $298.43 (Resistance: $302.97, Support: $298.37). Quarterly Fluctuation: Increased by 4.47%. Options Insights: Trend indicates less enthusiasm in single option buys, but steady underlying demand persists. Conclusion The earnings season is shaping up with substantial estimates across these companies, reflecting both performance improvements and market expectations. Investors should pay close attention to analysts' recommendations and recent stock price movements, which signal market sentiment. Each company's options activity reflects strategic positioning in anticipation of their earnings reports, underscoring the mixed sentiments in the market. Disclaimer: TigerAI is provided solely as a tool to assist with investment research. Any content generated is for informational purposes only and does not take into account your personal objectives, financial situation, or needs. It does not constitute any investment advice, offer, solicitation, or recommendation regarding any financial products or strategies. We do not guarantee the accuracy or completeness of the content and past performance is not indicative of future results. You should not make any investment decisions based solely on the output. Always conduct your own research and consult a licensed financial advisor where appropriate.
1.10K
·
11-03
🎁Capturing Top 10 Ex_dividend: BX, ETN, OKE, NVEC, PNW...
1. Which High Ex-dividend Stock (on 3 November ~ 7 November) do You Like the Most?Be Sure To Check Out the Last Chance to Buy the Top 10 High dividend stocks going to Ex-dividends This Week: many companies like $BX$ and $ETN$ showing below are about to give decent dividends into "your pocket".Editor's notes:A dividend-paying stock ex-dividend date, or ex-date, is very important to investors. In a nutshell, if you buy a dividend stock before the ex-dividend date, then you will receive the next upcoming dividend payment.If you purchase the stock on or after the ex-dividend date, you will not receive the dividend. Some investors utilize strategies whereby they will purchase stocks just prior to an ex-dividend date and sell shortly thereafter.2. YTD25 of the Above 10 Stocks are as Below:Accord
TOP$Omega Healthcare Investors(OHI)$ is a Maryland company with annual dividend yield of 6.2%. It has been giving out dividends every year without fail. It is my favorite here.
433
·
11-03
NFLX: Oversold Bounce Builds — Reclaiming $1,150 Key to Unlock $1,180–$1,220 Zone
$Netflix(NFLX)$ $1,118.86 (+2.74%): Oversold bounce on higher volume; reclaim $1,150 puts $1,180–$1,220 back in playMarket Recap (as of Oct 31, 2025) Netflix closed $1,118.86, range $1,101.98–$1,134.88. Volume 6.87M vs 3.41M avg (~2.0×), a solid accumulation day after a 3-week slide. Shares sit ~16.6% below the 52-wk high ($1,341.15).Technical read (Daily, TradingView)RSI(14) ≈ 41 → still below neutral, but curling.MACD below zero and widening negative; momentum bearish but moderating.Price now above 9-DEMA ~ $1,094 and testing 9-EMA ~ $1,122 → first step in a relief bounce.Structure: lower highs since early Oct; bulls need higher low > $1,100 then a close back over $1,150.Support / Resistance (near-term)Support: $1,085/$1055/$1000Resistance: $
217
·
11-03
ARKK: $90 Resistance Caps Rally — Tight Range Above EMA9 Signals Next Move
$ARK Innovation ETF(ARKK)$ $88.98 (+3.85%): Breakout attempt stalls near $90 ceiling; consolidation band tightening above EMA9Market Recap (as of Oct 31, 2025): ARK Innovation ETF (ARKK) advanced +3.85% to close at $88.98, extending its year-to-date gain to +54%. The move followed renewed buying in high-beta tech and speculative innovation names as Treasury yields eased slightly and market risk appetite returned. However, despite touching an intraday high of $89.95, the ETF again failed to sustain above the $90 psychological barrier, where sellers have repeatedly emerged since early October.Technical Indicators Analysis: Momentum is steady but capped. The MACD (1.57 vs 1.17) shows a narrow bullish spread, while histogram readings hover near zero,
920
·
11-03
Novo Nordisk: Oversold at $49, Needs $50 Reclaim to Stabilize Ahead of Earnings
$Novo-Nordisk A/S(NVO)$ $49.46 (−1.16%): Oversold test of the $49 handle; reclaim of $50–$50.5 needed to steady into earningsMarket Recap (as of Oct 31, 2025): Novo Nordisk ADR (NVO) closed at $49.46 (−1.16%), trading $48.49–$49.47 on the day. Volume 19.22M vs 15.19M avg (~1.26×), indicating distribution pressure. Overnight indications show $49.82 (+0.73%). Shares sit near YTD lows (52-wk range $45.05–$112.52).Technical Indicators Analysis:RSI(14) ≈ 26 (oversold). MACD is below signal with a negative histogram—down-momentum persists. Price is below short-term trend gauges (DEMA-9 ≈ $50.07, EMA-9 ≈ $52.06), so bulls need a quick reclaim of $50–$50.5 to avoid a deeper slide. Base case (1–3 wks): attempt to base above $48.5; bounce path opens if $50.5
379
·
11-03
Palantir: Fresh Breakout Holding Strong Above Short-Term Averages
$Palantir Technologies Inc.(PLTR)$ $200.47 (+3.04%): Fresh breakout; momentum firm while holding short MAsMarket Recap (as of Oct 31, 2025): Palantir closed at $200.47, up +3.04% on a wide $197.92–$204.18 range. Volume 52.70M vs 62.34M avg (~0.85×)—healthy but not blow-out, consistent with an orderly breakout. After-hours ~$203.56 (+1.54%).Technical Indicators Analysis:RSI(14) ~67 (bullish, not yet overbought).MACD(12,26,9) positive and widening (MACD ~5.32 > signal ~3.64; hist ~+1.67), confirming upside momentum.Price is above 9-EMA/9-DEMA (~$191/$197) and riding the short-term trend channel; holding prior breakout zone should keep buyers in control.Base case (1–3 weeks): sideways-to-up while above the breakout shelf; momentum continuation set
1.51K
·
11-03
DBS: Holding $53.20–$53.60 Key to Retest $54.80 High
$DBS(D05.SI)$ $53.92 (−0.02%): Sideways on light volume; hold $53.20–$53.60 keeps $54.20–$54.80 breakout path openMarket Recap (as of Oct 31, 2025): DBS finished at $53.92 on a tight tape (range $53.72–$54.08). Volume 1.32M vs 3.95M avg (~0.34×), pointing to simple consolidation rather than distribution. Shares sit ~1.6% below the 52-wk high $54.80.Technical Indicators Analysis: RSI(14) ~60 (firm, not overbought). MACD is slightly positive with a small histogram as price rides above short-term EMAs (9-period). Base case next 1–3 weeks: sideways-up while $53.2–$53.6 holds. A strong daily close back through $54.2 would set up a run at the prior high.Support / Resistance: Support: $53.20/$51.50 Resistance: $54.80/$54Valuation and Target Range: TTM
428
·
11-03
“Microsoft isn’t just riding the AI wave — it’s building the ocean. 🚀”
$Microsoft(MSFT)$ $ just served yet another reminder why it belongs in every growth portfolio. With Q1 FY26 earnings blowing past expectations, the company’s AI-cloud strategy is not theory anymore — it’s execution in overdrive. Reuters+3Seeking Alpha+3Meyka+3And the Fact is $Microsoft(MSFT)$ reported robust top-line growth and maintained strong cash flow, even in a volatile tech market.the impact is analysts kept the “Buy” rating despite short-term softness, signaling that the market is overlooking the long-term engine: Azure + AI + enterprise productivity. Hence consider setting a watch-entry near the recent pullback, or adding on weakness — this is less about timing and more about time-in-the-market.Wi
1.79K
·
11-03
Weekly & October List: Become Star Contributors & Win $66+$25 Vouchers!
🌟 Welcome to our "Top Contributor" Awards Program! 🌟Congratulations to the outstanding contributors who made last week unforgettable! You are the heartbeat of our community, and your dedication shines bright.From 27 October - 2 NovemberWeekly Top Contributor ($25 stock voucher):@nerdbull1669@xc__@Mickey082024Weekly Top Contributor ($15 stock voucher):@Optionspuppy@许智玮@orsiri @第N次大变革大分流
TOP🌟🌟🌟Thank You @TigerStars for your wonderful Tiger Stock Voucher. Congratulations to all my dear Tiger Friends who have also won too 🎉🎉🎉
1.39K
·
11-03
Can Hims Hold $45 Support and Rebuild Momentum?
$Hims & Hers Health Inc.(HIMS)$ $45.46 (+3.18%): First bounce attempt from a weak tape; $45 needs to hold to avoid a deeper fade toward $42Market Recap (as of Oct 31, 2025): Hims & Hers Health closed at $45.46 after trading $45.03–$47.24. Volume was ~4.1M vs ~28.7M avg (~0.14×), a light-participation day. Shares are ~38% below the 52-wk high ($72.98; low $19.15). Overnight indication shows a modest bid near $46.90.Technical Indicators Analysis: RSI(14) ~40 (neutral-bearish) after a multi-week drift; MACD stays below zero and under its signal, though the histogram’s decline is slowing—early signs of downside exhaustion. Price is hovering just above a minor horizontal shelf around $45; reclaiming $47–48 would be the first step to rebuild mom
1.29K
·
11-03
Can Grab Hold $6 and Reignite Its Late-September Breakout?
$Grab Holdings(GRAB)$ $6.01 (+0.50%): Holds the $6 handle; staying above $5.95 keeps the late-Sept breakout intactMarket Recap (as of Oct 31, 2025 close) Grab ticked up +0.50% to $6.01 on a tight session (range $5.95–$6.08). Volume 41.95M vs 44.53M avg (~0.94×), a quiet day near the highs. Shares sit ~9.2% below the 52-wk high $6.62. Overnight prints show ~$6.06 (+0.83%).Technical Indicators Analysis (Daily, YTD) RSI(14) ≈ 54 (neutral). MACD is slightly positive (MACD > signal; histogram ~+0.01) but flattening—momentum modest after October’s pullback. Price is riding above the 9-day EMA (~$5.94) / 9-day DEMA (~$5.98); holding that cluster preserves higher-low structure. Base case next 1–3 weeks: consolidation with a mild upward bias while $5.9
770
·
11-03
$AmovaEFund ChiNext S$(CXT.SI)$ I called this early....still not too late to get in [Cool]
836